Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial
Maneesh Kumarsing Beeharry(Shanghai Jiao Tong University), Zhenggang Zhu(Wuhan Center for Disease Control and Prevention), Zhong Yin Yang(Shanghai Jiao Tong University), Min Yan(Zhengzhou University), Xue Yao(Central Hospital of Zibo), Chen Li(Wuxi No.2 People's Hospital), Zhentian Ni(Ruijin Hospital), Ya Zheng(Shanghai Jiao Tong University), Chao Yan(Shanghai Jiao Tong University), Wentao Liu(Ruijin Hospital), Run Feng(Tongji University)
Cited by 33
Related Papers
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
|Oncotarget|2017|400
miR-126 functions as a tumour suppressor in human gastric cancer
|Cancer Letters|2010|298
CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
|Journal of Experimental & Clinical Cancer Research|2019|231
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell
|World Journal of Gastroenterology|2018|212